• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

美国 COVID-19 大流行前后阿片类药物纳洛酮处方的变化趋势。

Trends in Filled Naloxone Prescriptions Before and During the COVID-19 Pandemic in the United States.

机构信息

Center for Healthcare Delivery Science, Beth Israel Deaconess Medical Center, Boston, Massachusetts.

Department of Economics, Clark University, Worcester, Massachusetts.

出版信息

JAMA Health Forum. 2021 May 14;2(5):e210393. doi: 10.1001/jamahealthforum.2021.0393. eCollection 2021 May.

DOI:10.1001/jamahealthforum.2021.0393
PMID:35977309
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8796899/
Abstract

This cohort study analyzes the trends in filled naloxone prescriptions during the COVID-19 pandemic in the United States and compare these to opioid prescriptions and overall prescriptions.

摘要

这项队列研究分析了美国 COVID-19 大流行期间纳洛酮处方的趋势，并将其与阿片类药物处方和总体处方进行了比较。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1edc/8796899/9550cb297840/jamahealthforum-e210393-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1edc/8796899/9550cb297840/jamahealthforum-e210393-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1edc/8796899/9550cb297840/jamahealthforum-e210393-g001.jpg

相似文献

1
Trends in Filled Naloxone Prescriptions Before and During the COVID-19 Pandemic in the United States.美国 COVID-19 大流行前后阿片类药物纳洛酮处方的变化趋势。
JAMA Health Forum. 2021 May 14;2(5):e210393. doi: 10.1001/jamahealthforum.2021.0393. eCollection 2021 May.
2
Outpatient Opioid and Naloxone Prescribing Practices at an Academic Medical Center during the COVID-19 Pandemic.在 COVID-19 大流行期间，学术医疗中心的门诊阿片类药物和纳洛酮处方实践。
J Pain Palliat Care Pharmacother. 2022 Sep;36(3):178-186. doi: 10.1080/15360288.2022.2105471. Epub 2022 Aug 2.
3
Vital Signs: Pharmacy-Based Naloxone Dispensing - United States, 2012-2018.生命体征：2012-2018 年美国基于药房的纳洛酮配药情况。
MMWR Morb Mortal Wkly Rep. 2019 Aug 9;68(31):679-686. doi: 10.15585/mmwr.mm6831e1.
4
Medicaid prescription limits and their implications for naloxone accessibility.医疗补助处方药限制及其对纳洛酮可及性的影响。
Drug Alcohol Depend. 2021 Jan 1;218:108355. doi: 10.1016/j.drugalcdep.2020.108355. Epub 2020 Oct 17.
5
Association of Naloxone Coprescription Laws With Naloxone Prescription Dispensing in the United States.纳洛酮共开处方法律与美国纳洛酮处方配药的关联。
JAMA Netw Open. 2019 Jun 5;2(6):e196215. doi: 10.1001/jamanetworkopen.2019.6215.
6
Rates and Costs of Dispensing Naloxone to Patients at High Risk for Opioid Overdose in the United States, 2014-2018.美国 2014-2018 年向阿片类药物过量高危患者配给纳洛酮的比例和费用。
Drug Saf. 2020 Jul;43(7):669-675. doi: 10.1007/s40264-020-00923-6.
7
Racial inequities in U.S. naloxone prescriptions.美国纳洛酮处方中的种族不平等现象。
Subst Abus. 2020;41(2):232-244. doi: 10.1080/08897077.2019.1686721. Epub 2019 Nov 13.
8
The changing landscape of naloxone availability in the United States, 2011 - 2017.美国 2011-2017 年纳洛酮可及性的变化情况。
Drug Alcohol Depend. 2018 Oct 1;191:361-364. doi: 10.1016/j.drugalcdep.2018.07.017. Epub 2018 Aug 30.
9
Naloxone prescriptions following emergency department encounters for opioid use disorder, overdose, or withdrawal.阿片类药物使用障碍、过量或戒断急诊后开出的纳洛酮处方。
Am J Emerg Med. 2021 Sep;47:154-157. doi: 10.1016/j.ajem.2021.03.056. Epub 2021 Mar 24.
10
Naloxone Use by Emergency Medical Services During the COVID-19 Pandemic: A National Survey.《COVID-19 大流行期间急救医疗服务机构使用纳洛酮情况：全国性调查》。
J Addict Med. 2020 Dec;14(6):e369-e371. doi: 10.1097/ADM.0000000000000746.

引用本文的文献

1
Price Sensitivity and Information Barriers to the Take-Up of Naloxone.纳洛酮使用中的价格敏感性和信息障碍
Am Econ J Econ Policy. 2024 Nov;16(4):463-490. doi: 10.1257/pol.20230135.
2
Co-occurring illicit fentanyl use and psychiatric disorders in emergency department patients.急诊科患者中同时存在非法芬太尼使用和精神障碍的情况。
Sci Rep. 2025 Apr 1;15(1):11192. doi: 10.1038/s41598-025-92311-2.
3
A theoretical explanation of naloxone provision among primary care physicians and community pharmacists in Tennessee.田纳西州初级保健医生和社区药剂师提供纳洛酮的理论解释。

本文引用的文献

1
Analysis of Drug Test Results Before and After the US Declaration of a National Emergency Concerning the COVID-19 Outbreak.分析美国宣布新冠疫情为国家紧急状态前后的药物检测结果。
JAMA. 2020 Oct 27;324(16):1674-1677. doi: 10.1001/jama.2020.17694.
2
Nonfatal Opioid Overdoses at an Urban Emergency Department During the COVID-19 Pandemic.城市急诊科在 COVID-19 大流行期间的非致命性阿片类药物过量。
JAMA. 2020 Oct 27;324(16):1673-1674. doi: 10.1001/jama.2020.17477.
3
Addressing co-occurring public health emergencies: The importance of naloxone distribution in the era of COVID-19.
Res Social Adm Pharm. 2024 Oct;20(10):978-985. doi: 10.1016/j.sapharm.2024.07.001. Epub 2024 Jul 5.
4
State COVID-19 Policies and Drug Overdose Mortality Among Working-Age Adults in the United States, 2020.美国 2020 年工作年龄段成年人的州 COVID-19 政策与药物过量死亡率。
Am J Public Health. 2024 Jul;114(7):714-722. doi: 10.2105/AJPH.2024.307621. Epub 2024 May 2.
5
Changes to opioid overdose deaths and community naloxone access among Black, Hispanic and White people from 2016 to 2021 with the onset of the COVID-19 pandemic: An interrupted time-series analysis in Massachusetts, USA.2016 年至 2021 年期间，COVID-19 大流行期间美国马萨诸塞州黑人和西班牙裔及白人群体阿片类药物过量死亡和社区纳洛酮获取情况的变化：一项中断时间序列分析。
Addiction. 2023 Dec;118(12):2413-2423. doi: 10.1111/add.16324. Epub 2023 Aug 28.
6
The effect of the COVID-19 pandemic on the prescribing of opioid and opioid use disorder medications within an academic medical center in California.新冠疫情对加利福尼亚州一所学术医疗中心阿片类药物和阿片类药物使用障碍药物处方的影响。
Front Public Health. 2023 Jun 7;11:1105681. doi: 10.3389/fpubh.2023.1105681. eCollection 2023.
7
Application of The Consolidated Framework for Implementation Research to inform understanding of barriers and facilitators to the implementation of opioid and naloxone training on college campuses.应用实施研究综合框架来增进对大学校园阿片类药物和纳洛酮培训实施过程中的障碍与促进因素的理解。
Implement Sci Commun. 2023 May 23;4(1):56. doi: 10.1186/s43058-023-00438-y.
8
Opioid-involved overdose trainings delivered using remote learning modalities.远程学习模式下开展的阿片类药物相关过量培训。
Nurs Open. 2023 Jun;10(6):4132-4136. doi: 10.1002/nop2.1615. Epub 2023 Jan 21.
9
Increased solitary drug use during COVID-19: An unintended consequence of social distancing.新冠疫情期间孤独性药物使用增加：社交隔离的意外后果。
Int J Drug Policy. 2023 Jan;111:103923. doi: 10.1016/j.drugpo.2022.103923. Epub 2022 Nov 22.
10
High opioid doses, naloxone, and central nervous system active medications received by Medicare-enrolled adults.医疗保险覆盖的成年患者接受的高阿片类药物剂量、纳洛酮和中枢神经系统活性药物。
J Am Geriatr Soc. 2023 Jan;71(1):98-108. doi: 10.1111/jgs.18102. Epub 2022 Oct 26.
应对并发的突发公共卫生事件：纳洛酮分发在新冠疫情时代的重要性。
Int J Drug Policy. 2020 Sep;83:102872. doi: 10.1016/j.drugpo.2020.102872. Epub 2020 Jul 21.
4
The Impact of COVID-19 on Syringe Services Programs in the United States.2019冠状病毒病对美国注射器服务项目的影响。
AIDS Behav. 2020 Sep;24(9):2466-2468. doi: 10.1007/s10461-020-02886-2.
5
Opioid-overdose laws association with opioid use and overdose mortality.阿片类药物过量法规与阿片类药物使用和过量死亡率的关系。
Addict Behav. 2018 Nov;86:90-95. doi: 10.1016/j.addbeh.2018.03.014. Epub 2018 Mar 19.